Skip to main content
Clinical Trials/NCT05433064
NCT05433064
Recruiting
Not Applicable

Spinal Cord Stimulation for Spinal Cord Injury Patients - Regain Walk and Alleviate Pain

Buddhist Tzu Chi General Hospital1 site in 1 country12 target enrollmentMay 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Spinal Cord Injury
Sponsor
Buddhist Tzu Chi General Hospital
Enrollment
12
Locations
1
Primary Endpoint
Assessment of volitional movement of lower limbs using electromyographic analysis
Status
Recruiting
Last Updated
7 months ago

Overview

Brief Summary

The study aims to examine the plausible interventional mechanisms underlying the effects of epidural spinal cord stimulation.

Detailed Description

The purpose of this study is for the treatment of spinal cord injury (SCI) paralysis patients use the signal by electrophysiological analysis of epidural spinal cord stimulation (SCS) settings that promote lower limb activity so that SCI patients can restore the ability to stand and walk under multiple sensory stimuli and multimodal electrical stimulation rehabilitation. The investigators hope to establish an atresia nerve regulation strategy and observe that the original blocked neural circuits can improve nerve plasticity by SCS. Even can establish new connections through residual nerves and allow SCI patients to rebuild neural circuits without SCS to restore lower limb mobility and improve quality of life.

Registry
clinicaltrials.gov
Start Date
May 1, 2020
End Date
September 30, 2025
Last Updated
7 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Buddhist Tzu Chi General Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • SCI ASIA: A, B, C,D
  • Between 20 and 70 year of age
  • \>1 year post SCI
  • Complete or incomplete spinal cord injury.
  • Expected will undergo spinal cord stimulation surgery.
  • Continued rehabilitation after surgery for spinal cord injury.
  • Able to comply with procedures and follow up.
  • Stable medical condition without cardiopulmonary disease or dysautonomia that would contraindicate participation in lower extremity rehabilitation or testing activities

Exclusion Criteria

  • Have significant cognitive impairment (MMSE\<24).
  • Had a mental illness within one year or been treated in the past.
  • Have Major depressive disorder.
  • Active cancer diagnosis.
  • Painful musculoskeletal dysfunction, unhealed fracture, contracture, pressure sore, or urinary tract infection that might interfere with stand or step training.
  • Cardiovascular or musculoskeletal disease or injury that would prevent full participation in physical therapy intervention.
  • Unable to read and/or comprehend the consent form.
  • Have concerns about this trial and do not sign consent.

Outcomes

Primary Outcomes

Assessment of volitional movement of lower limbs using electromyographic analysis

Time Frame: To measure assessing change between pre-implant and every 3 months until 24 months.

Average of 6-repetitive EMG activity for each superficial component of muscles from a five-second ramp contraction to the end of a ten-second rest

6-Meter Time Up and Go (6TUG)

Time Frame: To measure assessing change between pre-implant and every 3 months until 24 months.

To evaluate gait for subjects who can walk by assistive device or independently.

Trunk stability measurement (trunk control assessment)

Time Frame: To measure assessing change between pre-implant and every 3 months until 24 months.]

To assess the sitting and walking dynamic balance by displacing the center of pressure (CoP) from the force plate and the trunk accelerations with a tri-axial accelerometer. The experiment includes sitting and walking.pressure (CoP) from the force plate and the trunk accelerations with tri-axial accelerometer.

Secondary Outcomes

  • Change in spasticity as measured by the Modified Ashworth Scale (MAS)(Baseline; at 1 - 4 - 7 - 13 - 19 - 25 months after the implantation)
  • Change in motor recovery as measured by the Total American Spinal Injury Association (ASIA) motor score(Baseline; at 1 - 4 - 7 - 13 - 19 - 25 months after implantation)
  • Change in Quality of Life (QOL) as measured by the World Health Organization Quality of Life (WHOQOL-BREF)(Baseline; at 1 - 4 - 7 - 13 - 19 - 25 months after implantation)
  • Change in ability (or inability) to safely balance as measured by the Berg Balance Scale (BBS)(Baseline; 7 months after implant)

Study Sites (1)

Loading locations...

Similar Trials